Type I interferon impairs specific antibody responses early during establishment of LCMV infection

10Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Elicitation of type I interferon (IFN-I) has been shown to both enhance and impair cell-mediated immune responses in acute and persistent viral infections, respectively. Here, we show that, in addition to its effect on T cells, IFN-I drives impairment of specific antibody responses through interaction with B cells in the acute phase of lymphocytic choriomeningitis virus (LCMV) infection. This impairment was limited to the T cell-dependent B cell response and was associated with disruption of B cell follicles, development of hypergammaglobulinemia (HGG), and expansion of the T follicular helper cell population. Antigen-specific antibody responses were restored by ablation of IFN-I signaling through antibody-mediated IFN-I receptor blockade and B cell-specific IFN-I receptor knockout. Importantly, IFN-I receptor deficiency in B cells also accelerated the development of LCMV neutralizing antibodies and alleviated HGG. These results provide a potential therapeutic target toward efficient treatment measures that limit immunopathology in persistent viral infections.

Cite

CITATION STYLE

APA

Daugan, M., Murira, A., Mindt, B. C., Germain, A., Tarrab, E., Lapierre, P., … Lamarre, A. (2016). Type I interferon impairs specific antibody responses early during establishment of LCMV infection. Frontiers in Immunology, 7(DEC). https://doi.org/10.3389/fimmu.2016.00564

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free